What is Nuvation Bio's software and technology licenses, net?

Nuvation Bio (NUVB) reported software and technology licenses, net of $3.82M in Q1 2026.

How has Nuvation Bio's software and technology licenses, net changed year-over-year?

Nuvation Bio's software and technology licenses, net decreased by 42.2% year-over-year, from $6.62M to $3.82M.

Nuvation Bio NUVB Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Bristol-Myers SquibbBMY

——

PfizerPFE

——

Nuvalent, Inc.NUVL

——

ImmunomeIMNM

——

ArriVent BioPharma, Inc.AVBP

——

Arcus BiosciencesRCUS

——

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's software and technology licenses, net?: Nuvation Bio (NUVB) reported software and technology licenses, net of $3.82M in Q1 2026.
How has Nuvation Bio's software and technology licenses, net changed year-over-year?: Nuvation Bio's software and technology licenses, net decreased by 42.2% year-over-year, from $6.62M to $3.82M.